From these results, we propose that angiotensin II (1–8), through the production of angiotensin IV (3–8), enhances spike protein binding to the host cell receptors, resulting in the exacerbation of SARS-CoV-2 infection as well as spike protein-mediated complications associated with COVID-19 (Figure 9). Here, AGT is linked to COVID-19.